Published in JAMA on February 25, 2004
Chronic disorders with episodic manifestations: focus on epilepsy and migraine. Lancet Neurol (2006) 2.23
Exercise as migraine prophylaxis: a randomized study using relaxation and topiramate as controls. Cephalalgia (2011) 1.79
Preventive pharmacologic treatments for episodic migraine in adults. J Gen Intern Med (2013) 1.70
Prophylaxis of migraine headache. CMAJ (2010) 1.54
Topiramate in migraine prophylaxis--results from a placebo-controlled trial with propranolol as an active control. J Neurol (2004) 1.43
Ezogabine (KCNQ2/3 channel opener) prevents delayed activation of meningeal nociceptors if given before but not after the occurrence of cortical spreading depression. Epilepsy Behav (2013) 1.40
Manual therapies for migraine: a systematic review. J Headache Pain (2011) 1.33
Assessing and managing all aspects of migraine: migraine attacks, migraine-related functional impairment, common comorbidities, and quality of life. Mayo Clin Proc (2009) 1.25
New drugs for migraine. J Headache Pain (2009) 1.02
Nephrolithiasis in topiramate users. Urol Res (2010) 1.01
The pharmacotherapy of chronic pain: a review. Pain Res Manag (2006) 1.01
The effect of sodium valproate on chronic daily headache and its subgroups. J Headache Pain (2008) 1.00
Cost-effectiveness analysis of interventions for migraine in four low- and middle-income countries. J Headache Pain (2015) 0.98
Prophylaxis of migraine: general principles and patient acceptance. Neuropsychiatr Dis Treat (2008) 0.98
A Comparative Effectiveness Meta-Analysis of Drugs for the Prophylaxis of Migraine Headache. PLoS One (2015) 0.95
Migraine prophylaxis, ischemic depolarizations, and stroke outcomes in mice. Stroke (2014) 0.95
Prescription of topiramate to treat alcohol use disorders in the Veterans Health Administration. Addict Sci Clin Pract (2013) 0.95
Preventive treatment in migraine and the new US guidelines. Neuropsychiatr Dis Treat (2013) 0.93
Current and prospective pharmacological targets in relation to antimigraine action. Naunyn Schmiedebergs Arch Pharmacol (2008) 0.92
The impact of migraine prevention on daily activities: a longitudinal and responder analysis from three topiramate placebo-controlled clinical trials. Health Qual Life Outcomes (2007) 0.91
Topiramate: Effects on cognition in patients with epilepsy, migraine headache and obesity. Ther Adv Neurol Disord (2013) 0.90
[Faster, higher, further. Current thinking on acute and prophylactic treatment of migraine]. Schmerz (2004) 0.89
A functional MRI study of language disturbances in subjects with migraine headache during treatment with topiramate. Neurol Sci (2008) 0.89
The effect of topiramate on cognitive fMRI. Epilepsy Res (2013) 0.89
Topiramate in the prevention and treatment of migraine: efficacy, safety and patient preference. Neuropsychiatr Dis Treat (2010) 0.89
Patient outcome in migraine prophylaxis: the role of psychopharmacological agents. Patient Relat Outcome Meas (2010) 0.88
Emerging drugs for migraine prophylaxis and treatment. MedGenMed (2006) 0.88
Topiramate-induced angle-closure glaucoma: cross-sensitivity with other sulphonamide derivatives causing anterior uveitis. Int Ophthalmol (2013) 0.86
Paroxysmal hemicrania responding to topiramate. J Neurol Neurosurg Psychiatry (2007) 0.85
The pharmacological management of migraine, part 2: preventative therapy. P T (2008) 0.85
Prophylaxis of migraine. Neuropsychiatr Dis Treat (2006) 0.84
Craniosacral therapy for migraine: protocol development for an exploratory controlled clinical trial. BMC Complement Altern Med (2008) 0.84
Evidence-Based Treatments for Adults with Migraine. Pain Res Treat (2015) 0.83
Recent advances in the diagnosis and management of migraine. BMJ (2006) 0.83
Topiramate in the prevention of migraine: a review of its efficacy, tolerability, and acceptability. Neuropsychiatr Dis Treat (2006) 0.83
Cinnarizine in refractory migraine prophylaxis: efficacy and tolerability. A comparison with sodium valproate. J Headache Pain (2008) 0.83
Topiramate: safety and efficacy of its use in the prevention and treatment of migraine. J Cent Nerv Syst Dis (2011) 0.82
The effectiveness of anticonvulsants in psychiatric disorders. Dialogues Clin Neurosci (2008) 0.82
Are the current IHS guidelines for migraine drug trials being followed? J Headache Pain (2010) 0.79
Central mechanism of action of antimigraine prophylactic drugs. Neurol Sci (2008) 0.78
Bayesian model selection techniques as decision support for shaping a statistical analysis plan of a clinical trial: an example from a vertigo phase III study with longitudinal count data as primary endpoint. BMC Med Res Methodol (2012) 0.78
Topiramate inhibits trigeminovascular activation: an intravital microscopy study. Br J Pharmacol (2005) 0.78
The effects of antiepileptic drugs on cognitive functional magnetic resonance imaging. Quant Imaging Med Surg (2015) 0.77
Levetiracetam in the preventive treatmentof transformed migraine: A prospective, open-label, pilot study. Curr Ther Res Clin Exp (2005) 0.77
Influence of NMDA and non-NMDA antagonists on acute and inflammatory pain in the trigeminal territory: a placebo control study. Arq Neuropsiquiatr (2008) 0.77
A pilot study of topiramate dosages for migraine prophylaxis in an Asian population. J Headache Pain (2010) 0.77
Prevention of episodic migraines with topiramate: results from a non-interventional study in a general practice setting. J Headache Pain (2009) 0.77
Genetic TPH2 variants and the susceptibility for migraine: association of a TPH2 haplotype with migraine without aura. J Neural Transm (Vienna) (2010) 0.76
sec-Butylpropylacetamide (SPD) has antimigraine properties. Cephalalgia (2015) 0.76
Topiramate in migraine progression. J Headache Pain (2009) 0.76
New drugs for the prevention and treatment of migraine: topiramate and BIBN 4096 BS. Expert Opin Pharmacother (2004) 0.76
Topiramate-induced paresthesia is more frequently reported by migraine than epileptic patients. Neurol Sci (2016) 0.76
Topiramate for migraine prevention: a randomized controlled trial. J Pediatr (2004) 0.75
Cinnarizine versus Topiramate in Prophylaxis of Migraines among Children and Adolescents: A Randomized, Double-Blind Clinical Trial. Iran J Child Neurol (2014) 0.75
Probable topiramate-induced hemiparesis. Can J Hosp Pharm (2010) 0.75
Optimizing prophylactic treatment of migraine: Subtypes and patient matching. Ther Clin Risk Manag (2008) 0.75
Meta-analysis of efficacy of topiramate in migraine prophylaxis. Neural Regen Res (2012) 0.75
Topiramate: the evidence for its therapeutic value in the prevention of migraine. Core Evid (2005) 0.75
Paroxysmal hemicrania responding to topiramate. BMJ Case Rep (2009) 0.75
Preventive agents for migraine: focus on the antiepileptic drugs. J Cent Nerv Syst Dis (2012) 0.75
Remarks on an educational training course on headache. Neurol Sci (2010) 0.75
Efficacy of zonisamide in migraineurs with nonresponse to topiramate. Biomed Res Int (2014) 0.75
Unveiling the relative efficacy, safety and tolerability of prophylactic medications for migraine: pairwise and network-meta analysis. J Headache Pain (2017) 0.75
Commentary. J Neurosci Rural Pract (2014) 0.75
Prophylactic Treatment of Migraine. Noro Psikiyatr Ars (2013) 0.75
Tolerability and Efficacy of Memantine as Add on Therapy in Patients with Migraine. Iran J Pharm Res (2017) 0.75
Current Treatment Options: Vestibular Migraine. Curr Treat Options Neurol (2017) 0.75
Key points in migraine prophylaxis: patient perspective. Neurol Sci (2009) 0.75
Is topiramate effective for migraine prevention in patients less than 18 years of age? A meta-analysis of randomized controlled trials. J Headache Pain (2017) 0.75
A prospective, open-label study of milnacipran in the prevention of headache in patients with episodic or chronic migraine. Neurol Sci (2013) 0.75
Sumatriptan-naproxen for acute treatment of migraine: a randomized trial. JAMA (2007) 3.16
Acetaminophen, aspirin, and caffeine versus sumatriptan succinate in the early treatment of migraine: results from the ASSET trial. Headache (2005) 2.80
Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial. Lancet Neurol (2010) 2.70
Essential role of cyclophilin A for hepatitis C virus replication and virus production and possible link to polyprotein cleavage kinetics. PLoS Pathog (2009) 1.94
Topiramate in migraine prevention: results of a large controlled trial. Arch Neurol (2004) 1.83
North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition consensus statement on the diagnosis and management of cyclic vomiting syndrome. J Pediatr Gastroenterol Nutr (2008) 1.72
Cohort mortality study of workers at seven beryllium processing plants: update and associations with cumulative and maximum exposure. Occup Environ Med (2010) 1.62
Polymorphism of the soluble epoxide hydrolase is associated with coronary artery calcification in African-American subjects: The Coronary Artery Risk Development in Young Adults (CARDIA) study. Circulation (2004) 1.52
Topiramate in migraine prophylaxis--results from a placebo-controlled trial with propranolol as an active control. J Neurol (2004) 1.43
Structural and functional vascular alterations and incident hypertension in normotensive adults: the Multi-Ethnic Study of Atherosclerosis. Am J Epidemiol (2009) 1.39
Perceptions of student-observers in the operating room. J Surg Res (2011) 1.39
Evaluation of the association between persistent organic pollutants (POPs) and diabetes in epidemiological studies: a national toxicology program workshop review. Environ Health Perspect (2013) 1.36
Abrogation of oxidative stress improves insulin sensitivity in the Ren-2 rat model of tissue angiotensin II overexpression. Am J Physiol Endocrinol Metab (2004) 1.33
Forty-year mortality from cardiovascular diseases and all causes of death in the US Railroad cohort of the Seven Countries Study. Eur J Epidemiol (2004) 1.28
Risk of lung cancer associated with quantitative beryllium exposure metrics within an occupational cohort. Occup Environ Med (2010) 1.10
Improving indoor environmental quality for public health: impediments and policy recommendations. Environ Health Perspect (2007) 1.10
Evaluation of HUD-funded lead hazard control treatments at 6 years post-intervention. Environ Res (2006) 1.09
Trajectories of kidney function decline in young black and white adults with preserved GFR: results from the Coronary Artery Risk Development in Young Adults (CARDIA) study. Am J Kidney Dis (2013) 1.07
Effect of topiramate or carbamazepine on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in healthy obese and nonobese female subjects. Epilepsia (2003) 1.05
Topiramate improves health-related quality of life when used to prevent migraine. Headache (2005) 1.03
Housing and allergens: a pooled analysis of nine US studies. Environ Res (2009) 1.01
Chronic lymphocytic leukaemia and radiation: findings among workers at five US nuclear facilities and a review of the recent literature. Br J Haematol (2007) 0.99
Pharmacokinetic interactions of topiramate. Clin Pharmacokinet (2004) 0.97
Antidepressants in the treatment of migraine headache. Curr Pain Headache Rep (2003) 0.97
Intakes of long-chain omega-3 (n-3) PUFAs and fish in relation to incidence of asthma among American young adults: the CARDIA study. Am J Clin Nutr (2012) 0.96
Use of the emergency department for severe headache. A population-based study. Headache (2008) 0.96
Botulinum Toxin Type A in the treatment of chronic migraine without medication overuse. Headache (2007) 0.95
Risk of chronic myeloid and acute leukemia mortality after exposure to ionizing radiation among workers at four U.S. nuclear weapons facilities and a nuclear naval shipyard. Radiat Res (2007) 0.95
The Gutenberg Bibles: analysis of the illuminations and inks using Raman spectroscopy. Anal Chem (2005) 0.93
Mechanisms of hearing loss after blast injury to the ear. PLoS One (2013) 0.92
Atomoxetine treatment of ADHD in children with comorbid Tourette syndrome. J Atten Disord (2007) 0.92
Migraine headache is present in the aura phase: a prospective study. Neurology (2012) 0.91
Efficacy and tolerability of almotriptan in adolescents: a randomized, double-blind, placebo-controlled trial. Headache (2008) 0.91
The impact of migraine prevention on daily activities: a longitudinal and responder analysis from three topiramate placebo-controlled clinical trials. Health Qual Life Outcomes (2007) 0.91
The Macrostomum lignano EST database as a molecular resource for studying platyhelminth development and phylogeny. Dev Genes Evol (2006) 0.88
Effects of HUD-supported lead hazard control interventions in housing on children's blood lead. Environ Res (2010) 0.86
Intensity of quartz-tungsten-halogen light-curing units used in private practice in Toronto. J Am Dent Assoc (2005) 0.86
Treating early versus treating mild: timing of migraine prescription medications among patients with diagnosed migraine. Headache (2005) 0.85
Comparison of heparin-coated and conventional split-tip hemodialysis catheters. Cardiovasc Intervent Radiol (2009) 0.85
Posttraumatic Headache. Curr Treat Options Neurol (2004) 0.84
A randomized, double-blind, placebo-controlled study of the efficacy, safety, and tolerability of adjunctive carisbamate treatment in patients with partial-onset seizures. Epilepsia (2011) 0.84
Efficacy and tolerability of a new powdered formulation of diclofenac potassium for oral solution for the acute treatment of migraine: results from the International Migraine Pain Assessment Clinical Trial (IMPACT). Cephalalgia (2010) 0.83
Carisbamate as adjunctive treatment of partial onset seizures in adults in two randomized, placebo-controlled trials. Epilepsia (2009) 0.83
Chronic migraine headache prevention with noninvasive vagus nerve stimulation: The EVENT study. Neurology (2016) 0.82
Migraine frequency and health utilities: findings from a multisite survey. Value Health (2008) 0.82
Comprehensive inpatient treatment of refractory chronic daily headache. Headache (2009) 0.81
Differences in mortality by radiation monitoring status in an expanded cohort of Portsmouth Naval Shipyard workers. J Occup Environ Med (2004) 0.81
National evaluation of the US Department of Housing and Urban Development Lead-Based Paint Hazard Control Grant Program: study methods. Environ Res (2005) 0.81
Open-label, long-term tolerability of naratriptan for short-term prevention of menstrually related migraine. Headache (2007) 0.81
Sumatriptan/Naproxen sodium for migraine: efficacy, health related quality of life, and satisfaction outcomes. Headache (2007) 0.80
Secondary headaches in children and adolescents. Semin Pediatr Neurol (2010) 0.80
Risk of lung cancer and leukemia from exposure to ionizing radiation and potential confounders among workers at the Portsmouth Naval Shipyard. Radiat Res (2005) 0.80
Homogeneity in the relationship of serum cholesterol to coronary deaths across different cultures: 40-year follow-up of the Seven Countries Study. Eur J Cardiovasc Prev Rehabil (2008) 0.80
Randomized, controlled trial of telcagepant over four migraine attacks. Cephalalgia (2010) 0.79
Efficacy of intravenous diphenhydramine versus intravenous DHE-45 in the treatment of severe migraine headache. Curr Pain Headache Rep (2005) 0.79
Chronic headache: New advances in treatment strategies. Neurology (2002) 0.79
Clomiphene citrate as a new treatment for SUNCT: hormonal manipulation for hypothalamic-influenced trigeminal autonomic cephalalgias. Headache (2005) 0.79
Analysis of pooled data from two pivotal controlled trials on the efficacy of topiramate in the prevention of migraine. J Am Osteopath Assoc (2007) 0.78
Topiramate and lamotrigine pharmacokinetics during repetitive monotherapy and combination therapy in epilepsy patients. Epilepsia (2003) 0.78
Divalproex sodium extended-release for the prophylaxis of migraine headache in adolescents: results of a stand-alone, long-term open-label safety study. Headache (2008) 0.78
Migraine treatment with rizatriptan and non-triptan usual care medications: a pharmacy-based study. Headache (2004) 0.78
Editorial to the guidelines for trials of behavioral treatments for recurrent headache. Headache (2005) 0.78
Efficacy and tolerability of coadministration of rizatriptan and acetaminophen vs rizatriptan or acetaminophen alone for acute migraine treatment. Headache (2008) 0.78
Time course of adverse events in patients with localization-related epilepsy receiving topiramate added to carbamazepine. Epilepsia (2005) 0.77
Topiramate, carbamazepine, and valproate monotherapy: double-blind comparison in children with newly diagnosed epilepsy. J Child Neurol (2004) 0.77
Sumatriptan-naproxen fixed combination for acute treatment of migraine: a critical appraisal. Drug Des Devel Ther (2010) 0.77
Early and late coronary deaths in the US Railroad study predicted by major coronary risk factors. Eur J Cardiovasc Prev Rehabil (2004) 0.77
Opioid tolerance or rather opioid-induced pain sensitivity. Headache (2004) 0.76
Psychiatric comorbidity with chronic headache: evidence-based clinical implications--introduction to the supplement. Headache (2006) 0.76
Efficacy of halogen photopolymerization units in private dental offices in Toronto. J Can Dent Assoc (2005) 0.75
Botulinum toxin and chronic facial pain. J Pain (2002) 0.75
Head or neck injury increases the risk of chronic daily headache: a population-based study. Neurology (2008) 0.75
Preventive antimigraine therapy: the long-term outlook. Lancet Neurol (2007) 0.75
Developmental plasticity, straight from the worm's mouth. Cell (2013) 0.75
Unusual headache syndromes in children. Curr Pain Headache Rep (2007) 0.75
Epithelial downgrowth after type 1 Boston keratoprosthesis manifesting as tractional retinal detachment and epiretinal membrane. Arch Ophthalmol (2012) 0.75
Abrupt onset and termination of cutaneous allodynia (central sensitization) during attacks of SUNCT. Headache (2005) 0.75
Evaluating the impact of a pharmacist's absence from an antimicrobial stewardship team. Am J Health Syst Pharm (2013) 0.75
Are pediatric grand rounds dead? J Pediatr (2012) 0.75
Necrolytic migratory erythema-like presentation for cystic fibrosis. J Am Acad Dermatol (2008) 0.75
Electroencephalography: a primer. Pediatr Rev (2012) 0.75
Dynamic processing allocation in video. IEEE Trans Pattern Anal Mach Intell (2011) 0.75
Structure and dynamics of surfactant interfaces in organically modified clays. J Phys Chem B (2008) 0.75
Evaluation of a multiple sclerosis cluster among nurses in an inpatient oncology ward. J Occup Environ Hyg (2015) 0.75
Treatment of headache following triptan failure after successful triptan therapy. Curr Treat Options Neurol (2015) 0.75
Headaches in children and adolescents. Pediatr Ann (2010) 0.75
Long-term experience with ZENPEP in infants with exocrine pancreatic insufficiency associated with cystic fibrosis. J Pediatr Gastroenterol Nutr (2014) 0.75
Women and headache: a treatment approach based on life stages. Cleve Clin J Med (2002) 0.75
677: DESCRIPTION OF CRITICALLY ILL CHILDREN WITH VERY ELEVATED PROCALCITONIN LEVELS. Crit Care Med (2016) 0.75
Please don't let her suffer like I did! Expert Rev Neurother (2005) 0.75
Teaching case: Sinus headache. Headache (2007) 0.75
Effectiveness and safety of diclofenac epolamine topical patch 1.3% for the treatment of acute pain due to back strain: an open-label, uncontrolled study. Phys Sportsmed (2011) 0.75